Abdul Mannan: Recognition and Management of Febrile Non-Haemolytic Transfusion Reactions in Clinical Practice
Abdul Mannan, Consultant Hematologist at Betsi Cadwaladr University Health Board, shared a post on LinkedIn:
“FNHTR is the most common transfusion reaction — but its real danger is that it can mimic the early signs of a haemolytic transfusion reaction (HTR), which is life-threatening.
The hook should create that tension: common but terrifying until proven otherwise.
Fever during a blood transfusion.
Every junior doctor freezes.
Is this dangerous?
Do I stop the blood?
Is my patient haemolysing?
Most of the time? It’s FNHTR.
But you can’t assume that.
Here’s the framework:
What’s happening:
- Recipient antibodies attack donor white cells
- Or cytokines accumulate in the stored bag
- Result: fever ≥38°C or a ≥1°C rise, with chills and rigors
The diagnosis is by exclusion:
- No hypotension
- No respiratory distress
- No haemolysis
If ANY of these are present — think harder.
What to do:
- STOP the transfusion immediately
- Send blood for labs (FBC, DAT, repeat group and screen)
- Give paracetamol
- Only RESTART slowly once you’ve ruled out something serious
Prevention:
- Leucodepletion of blood components
- All UK blood products are now leucodepleted — this has cut FNHTR rates dramatically
The 2023 SHOT report still lists FNHTR as the most reported transfusion complication in the UK.
Common doesn’t mean trivial.
When you stop that bag — you’re not overreacting.
You’re doing exactly the right thing.
What’s the most challenging transfusion reaction you’ve managed?”
Other posts from Abdul Mannan on Hemostasis Today.
-
Aug 14, 2026, 08:17Maha Othman: Celebrating Research and Collaboration at the Sinclair Cancer Research Institute 2026 Annual Retreat
-
Aug 14, 2026, 06:26Delivering Gene Therapy in Hemophilia – ISTH
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation